The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
H | Systemic hormonal preparations, excl. Sex hormones and insulins | |
2
|
H04 | Pancreatic hormones | |
3
|
H04A | Glycogenolytic hormones | |
4
|
H04AA | Glycogenolytic hormones |
| Code | Title | |
|---|---|---|
| H04AA01 | Glucagon | |
| H04AA02 |
| Active Ingredient |
|---|
|
Dasiglucagon is a glucagon receptor agonist analogue, which increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating glycogen breakdown and release of glucose from the liver. Hepatic stores of glycogen are necessary for dasiglucagon to produce an antihypoglycaemic effect. |
|
Glucagon is a hyperglycaemic agent that mobilises hepatic glycogen, which is released into the blood as glucose. Glucagon inhibits the tone and motility of the smooth muscle in the gastrointestinal tract. |
| Document | Type | Information Source | |
|---|---|---|---|
| GLUCAGEN Powder and solvent for solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| OGLUO Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ZEGALOGUE Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) |